Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronomodulated Preoperative Chemoradiation for Biliary Tract Cancer
NCT00030511Phase 2Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Oct 2001
- Primary completion
- Jul 2003
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil in extrahepatic bile duct cancer and liver cancer, sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Pathologic Response Rate. Started Oct 2001; status: terminated.
02
Drugs
fluorouracil
03
Conditions
extrahepatic bile duct cancerliver cancer
Beyond the preview
Go deeper on NCT00030511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030511.